This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
This high technology apparatus for the forearm is helping to restore hand movement in stroke patients. ~ Detroit Medical Center Submitted by Detroit Medical Center
NEW YORK (Reuters Health) – A test panel of four biomarkers of cerebral ischemia shows promise as an aid to early evaluation and management of patients with symptoms…
NEW YORK (Reuters Health) – The increasing prevalence of autism cases in California seen since the 1990s is in large part real, not simply the result of changes…
NEW YORK (Reuters Health) – Treatment with the nonsteroidal selective estrogen receptor modulator raloxifene may heighten the risk of venous thromboembolic events and stroke deaths in postmenopausal women…
NEW YORK (Reuters Health) – In high-risk atrial fibrillation patients who are candidates for anticoagulation, stroke usually occurs if warfarin is not used or drug levels are subtherapeutic,…
NEW YORK (Reuters Health) – In the largest cohort study to date, statin treatment was found to reduce the incidence of Alzheimer’s disease, regardless of the drug’s lipophilicity…
By David Douglas NEW YORK (Reuters Health) – There appears to be a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced relief of anxiety, Swedish…
Neelam Misra, MD, Assistant Medical Director, Manhattan Total Health, discusses acupuncture and effects on the autonomic nervous system. References and Resources Kawakita K, Shinbara H, Imai K, Fukuda…
S. Ausim Azizi, MD, PhD, Chairperson/Professor, Department of Neurology, Temple University School of Medicine, discusses Parkinson’s Disease. References and Resources Tessa C, Giannelli M, Nave RD, Lucetti C,…
Current long-term use of calcium channel blockers was associated with a significantly reduced risk of a Parkinson disease diagnosis, while the risk was not materially altered for users…
